Sponsor Pipeline

POLYSAN Scientific & Technological Pharmaceutical Company Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Phase 3
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT06514976
Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not…		 overall status: Recruiting → Unknown
Active Trials by Phase
Phase 2/3
1
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT06955416 REAMBERIN® 1.5% in Rehydration Therapy of Diabetic Ketoacidosis Diabetic Ketoacidosis Recruiting
Not specified
NCT06735898 Evaluation of the Efficacy of Permanent Course Combined Therapy With CYTOFLAVIN®… Ischemic Stroke Recruiting
NCT07066540 Trial of the Efficacy and Safety of Use of Drug Product Reamberin® for Pathogenetic… Viral Enteric Infection Recruiting
Disease Areas
Stroke (1)
Get alerts when POLYSAN Scientific & Technological Pharmaceutical Company's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free